衰弱对颈动脉血运重建术后临床结局的影响
基于美国全国住院患者样本2005-2017年数据,纳入1426343例颈动脉血运重建患者,其中59158例(4.2%)被判定为衰弱。衰弱患者院内死亡、术后卒中、心肌梗死及卒中/死亡复合终点均显著高于非衰弱患者,且住院费用和住院时间增加。风险模型应纳入衰弱评估以指导管理。
要点
- 衰弱患者颈动脉血运重建后死亡、卒中、心梗风险显著升高。
- 衰弱与住院费用增加和住院时间延长独立相关。
- 颈动脉支架术患者中衰弱比例高于内膜剥脱术患者。
核心结论
- 衰弱与颈动脉血运重建患者的不良结局和更多资源使用相关。
研究设计与样本
- 使用2005-2017年美国全国住院患者样本,纳入接受颈动脉内膜剥脱术或颈动脉支架术的患者1426343例。
- 采用约翰霍普金斯调整临床组衰弱指标的定义诊断代码判定衰弱,共59158例(4.2%)为衰弱。
- 使用多变量回归评估衰弱与院内死亡、术后卒中、心肌梗死、住院费用和住院时间的关联。
主要发现
- 衰弱患者中79.4%接受颈动脉内膜剥脱术,20.6%接受颈动脉支架术。
- 颈动脉支架术患者中衰弱比例高于内膜剥脱术患者(6.0% vs. 3.8%,P < 0.001)。
- 衰弱患者较非衰弱患者死亡率(2.2% vs. 0.5%,P < 0.001)、术后卒中(2.6% vs. 1.0%,P < 0.001)、心肌梗死(2.2% vs. 0.8%,P < 0.001)及卒中/死亡(4.4% vs. 1.4%,P < 0.001)均更高。
- 校正后衰弱与死亡率(AOR = 1.59,95% CI: 1.30-1.80,P < 0.001)、卒中(AOR = 1.66,95% CI: 1.38-1.83,P < 0.001)、心肌梗死(AOR = 1.51,95% CI: 1.29-1.72,P < 0.001)及卒中/死亡(AOR = 1.62,95% CI: 1.45-1.81,P < 0.001)风险增加相关。
- 衰弱与住院费用增加(β = +$5,980,95% CI: $5,490-$6,470,P < 0.001)和住院时间延长(β = +2.6天,95% CI: 2.4-2.8,P < 0.001)相关。
临床怎么用
- 在颈动脉血运重建术前应评估衰弱状态,以识别高风险患者并辅助决策。
- 对衰弱患者应加强围手术期管理,并合理预期住院时间和费用可能增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frailty has been increasingly recognized as an important risk factor for vascular procedures. To assess the impact of frailty on clinical outcomes and resource utilization in patients undergoing carotid revascularization using a national cohort. METHODS: The 2005-2017 National Inpatient Sample was used to identify patients who underwent carotid endarterectomy (CEA) or carotid stenting (CAS). Patients were classified as frail using diagnosis codes defined by the Johns Hopkins Adjusted Clinical Groups frailty indicator. Multivariable regression was used to evaluate associations between frailty and in-hospital mortality, postoperative stroke, myocardial infarction (MI), hospitalization costs, and length of stay (LOS). RESULTS: Of 1,426,343 patients undergoing carotid revascularization, 59,158 (4.2%) were identified as frail. Among frail patients, 79.4% underwent CEA and 20.6% underwent CAS. Compared to CEA, a greater proportion of patients undergoing CAS were frail (6.0% vs. 3.8%, P < 0.001). Compared to the nonfrail cohort, frail patients had higher rates of mortality (2.2% vs. 0.5%, P < 0.001), postoperative stroke (2.6% vs. 1.0%, P < 0.001), MI (2.2% vs. 0.8%, P < 0.001), and stroke/death (4.4% vs. 1.4%, P < 0.001). After adjustment, frailty was associated with increased odds of mortality (AOR = 1.59, 95% CI: 1.30-1.80, P < 0.001), stroke (AOR = 1.66, 95% CI: 1.38-1.83 P < 0.001), MI (AOR = 1.51, 95% CI: 1.29-1.72, P < 0.001), and stroke/death (AOR = 1.62, 95% CI: 1.45-1.81, P < 0.001). Furthermore, frailty was associated with increased hospitalization costs (β = +$5,980, 95% CI: $5,490-$6,470, P < 0.001) and LOS (β = +2.6 days, 95% CI: 2.4-2.8, P < 0.001). CONCLUSIONS: Frailty is associated with adverse outcomes and greater resource use for those undergoing carotid revascularization. Risk models should include an assessment of frailty to guide management and improve outcomes for these high-risk patients.
引用
- Mandelbaum AD, Hadaya J, Ulloa JG, et al. Impact of Frailty on Clinical Outcomes after Carotid Artery Revascularization. Ann Vasc Surg. 2021. PMID: 33556528. doi:10.1016/j.avsg.2020.12.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。